Lb Pharmaceuticals (LBRX) Current Leases (2024 - 2026)

Lb Pharmaceuticals' Current Leases history runs 3 years deep, the most recent figure standing at $730000.0 for Q1 2026.

• In Q1 2026, Current Leases changed N/A year-over-year to $730000.0; the TTM figure through Mar 2026 stood at $730000.0 (changed N/A YoY), while the FY2025 annual figure was $730000.0, up 49.9% from the prior year.
• Current Leases for Q1 2026 stood at $730000.0, roughly flat from $730000.0 in the prior quarter.
• The five-year high for Current Leases was $730000.0 in Q3 2025, with the low at $487000.0 in Q4 2024.
• The 3-year median for Current Leases is $730000.0 (2025), against an average of $669250.0.
• Peak annual rise in Current Leases reached 49.9% in 2025, while the deepest fall reached 49.9% in 2025.
• Lb Pharmaceuticals' Current Leases stood at $487000.0 in 2024, then jumped by 49.9% to $730000.0 in 2025, then changed by 0.0% to $730000.0 in 2026.
• Business Quant data shows LBRX's Current Leases at $730000.0 in Q1 2026, $730000.0 in Q4 2025, and $730000.0 in Q3 2025.